Inorganic Chemistry
Article
(C27H42N10B2OCo): C 53.76, H 7.02, N 23.22; found: C 53.39, H
6.75, N 22.98.
(C30H37N10B2Br3Co): C 42.00, H 4.35, N 16.33; found: C 41.70,
H 4.53, N 15.94.
[CoII(TpMe2,4Me)(LPh)] (6). The crude complex was recrystallized
from MeCN at −30 °C to give the title complex as a reddish-brown
powder (173 mg, 0.261 mmol, 11.7%). Recrystallization from a
MeCN solution at −30 °C gave a red block crystal suitable for X-ray
crystallography. FT-IR (KBr): ν = 3119 (w), 3041 (w), 2995 (w),
2913 (vs), 2860 (m), 2505 (vs, νBH), 1284 cm−1 (s, νBC). UV−vis
(CH2Cl2, r.t.): λ = 681 nm (ε = 27.7 M−1 cm−1), 498 nm (ε = 116.7
The other complexes were prepared by following the same
procedure. In the synthesis of the complexes 2−6, LiLX, which was
generated by the reaction of HLX with n-butyllithium at −80 °C,
reacted with the corresponding acetate complexes [CoII(TpMe2,4R)-
(OAc)] (where R = H for 2−4, Br for 5, and Me for 6, respectively).
[CoII(TpMe2,4H)(LMe)] (2). The crude complex was recrystallized from
MeCN at −30 °C to give the title complex as a light pink powder
(50.7 mg, 0.091 mmol, 46.4%). Recrystallization from a CH2Cl2/
MeCN solution at −30 °C gave a red block crystal suitable for X-ray
crystallography. FT/IR (KBr): ν = 3117 (w), 2911 (vs), 2517 (m,
νBH), 1287 cm−1 (vs, νBC). UV−vis (CH2Cl2, r.t.): λ = 537 nm (ε =
60.0 M−1 cm−1), 500 nm (ε = 71.8 M−1 cm−1), 420 nm (ε = 71.0 M−1
cm−1). 1H NMR (600 MHz, CDCl3, 25 °C, TMS): δ = 59.01 (s, 1H;
B-H), 37.98 (s, 3H; Pz-H), 31.14 (s, 2H; Im), 29.60 (s, 6H; Im-CH3),
25.96 (br, 9H; Pz-CH3), 1.54 (s, 6H; B-CH3), −17.77 (br, 2H; Im),
−43.88 (br, 9H; Pz-CH3). ESI-MS+ (MeCN): m/z = 388 ([M − LMe
+ MeCN]+), 544 ([M − CH3]+). Magnetic moment (Evans method,
r.t., CDCl3): μeff = 3.5 μB. Elemental analysis calcd (%) for
[CoII(TpMe2,4H)(LMe)] (C25H38N10B2Co): C 53.70, H 6.85, N
25.05; found: C 53.65, H 7.06, N 24.79.
1
M−1 cm−1), 420 nm (ε = 103.3 M−1 cm−1). H NMR (600 MHz,
CDCl3, 25 °C, TMS): δ = 56.81 (br, 1H; B-H), 33.61 (br, 2H; Im),
23.67 (s, 9H; Pz-CH3), 22.43 (s, 6H; Im-CH3), 16.36 (s, 2H; Ph),
15.81 (s, 2H; Ph), 14.34 (s, 1H; Ph), 7.28 (br, 9H; Pz-CH3), 6.10 (s,
3H; B-CH3), −24.90 (br, 2H; Im), −43.24 (br, 9H; Pz-CH3). ESI-
MS+ (MeCN): m/z = 664 ([M + H]+). Magnetic moment (Evans
method, r.t., CDCl3): μeff = 3.4 μB. Elemental analysis calcd (%) for
[CoII (TpMe2,4Me)(LPh)]·0.5H2O (C33H47N10B2CoO0.5): C 58.95, H
7.05, N 20.83; found: C 58.89, H 7.25, N 20.94.
4.3.2. [CoII(TpMe2,4H)(Bp)] (7). This Bp complex was also synthesized
by the same procedure for 1, where KBp was used instead of LiLOiPr
.
This complex was recrystallized from MeCN at −30 °C to give the
title complex as a red-purple powder (193.3 mg, 0.348 mmol, 38.9%).
Recrystallization from a CH2Cl2/pentane solution at room temper-
ature gave a red block crystal suitable for X-ray crystallography. FT/IR
(KBr): ν = 3133 (w), 2959 (vs), 2927 (vs), 2861 (vs), 2509 (vs, νBH),
2432 cm−1 (vs, νBH). UV−vis (CH2Cl2, r.t.): λ = 537 nm (ε = 77.4
M−1 cm−1), 506 nm (ε = 81.5 M−1 cm−1), 422 nm (ε = 55.0 M−1
[CoII(TpMe2,4H)(LnBu)] (3). The crude complex was recrystallized from
MeCN at −30 °C to give the title complex as a brown powder (89.5
mg, 0.149 mmol, 30.3%). Further recrystallization from a CH2Cl2/
MeCN solution at −30 °C gave a brown block crystal suitable for X-
ray crystallography. FT-IR (KBr): ν = 3120 (w), 2948 (vs), 2925 (vs),
2866 (vs), 2511 (m, νBH), 1285 cm−1 (m, νBC). UV−vis (CH2Cl2,
r.t.): λ = 539 nm (ε = 77.8 M−1 cm−1), 501 nm (ε = 89.2 M−1 cm−1),
1
cm−1). H NMR (600 MHz, CDCl3, 25 °C, TMS): δ = 137.04 (br,
2H; B(Bp)-H), 74.54 (br, 1H; Pz(Tp)-H), 73.15 (s, 2H; Pz(Tp)-H),
55.76 (s, 2H; Pz(Bp)-H), 45.95 (s, 3H; Pz(Tp)-CH3), 44.88 (s, 6H;
Pz(Tp)-CH3), 16.16 (s, 2H; Pz(Bp)-H), −49.48 (s, 6H; Pz(Tp)-
CH3), −50.68 (s, 3H; Pz(Tp)-CH3), −67.03 (s, 2H; Pz(Bp)-H). ESI-
MS+ (MeOH): m/z = 503 (M+). Magnetic moment (Evans method,
r.t., CDCl3): μeff = 4.2 μB. Elemental analysis calcd (%) for
[CoII(TpMe2,4H)(Bp)] (C21H30N10B2Co): C 50.14, H 6.01, N 27.84;
found: C 49.70, H 5.53, N 27.39.
4.4. Thermodynamic Analysis of the Oxygenation of 1−7.
UV−vis spectra of 1−7 in THF were measured at low temperature
under various O2 partial pressures (p(O2)). Argon and dioxygen gas
were mixed using two mass flow controllers and passed through
approximately 0.17 mM solutions (gas flow 100 mL min−1) of the
complex in a quartz cell (1 cm path length). The gas mixture was
bubbled through the solution for 0.5 h before the measurement to
ensure that equilibrium had been reached. The growth of absorption
band shoulders, absent in the deoxy form, upon oxygenation were
monitored at 390 nm. The strong binding affinity resulted in
saturation at high pO2 values, and the measurements obtained at these
partial pressures could not be used in the determination of the
1
420 nm (ε = 79.4 M−1 cm−1). H NMR (600 MHz, CDCl3, 25 °C,
TMS): δ = 58.83 (br, 1H; B-H), 36.78 (s, 3H; Pz-CH3), 30.41 (br,
2H; Im), 29.49 (br, 2H; nBu-CH2), 28.33 (s, 6H; Im-CH3), 25.54 (br,
9H; Pz-CH3), 1.49 (br, 3H; B-CH3), −10.32 (s, 3H; nBu-CH3),
−16.14 (br, 2H; Im), −21.91 (s, 2H; nBu-CH2), −22.80 (br, 2H; nBu-
CH2), −44.15 (s, 9H; Pz-CH3). ESI-MS+ (MeCN): m/z = 544 ([M −
C4H9]+). Magnetic moment (Evans method, r.t., CDCl3): μeff = 3.6
μB. Elemental analysis calcd (%) for [CoII(TpMe2,4H)(LnBu)]
(C28H44N10B2Co): C 55.93, H 7.38, N 23.30; found: C 55.68, H
7.01, N 23.25.
[CoII(TpMe2,4H)(LPh)] (4). The crude complex was recrystallized from
DMF at −30 °C to give the title complex as a brown powder (45.1
mg, 0.073 mmol, 7.4%). Recrystallization from a CH2Cl2/MeCN
solution at −30 °C gave a red block crystal suitable for X-ray
crystallography. FT-IR (KBr): ν = 3120 (w), 2953 (vs), 2909 (vs),
2513 (m, νBH), 1285 cm−1 (m, νBC). UV−vis (CH2Cl2, r.t.): λ = 663
1
nm (ε = 21.1 M−1 cm−1), 496 nm (ε = 91.2 M−1 cm−1). H NMR
(600 MHz, CDCl3, 25 °C, TMS): δ = 48.87 (br, 1H; B-H), 32.51 (br,
3H; Pz-H), 30.37 (br, 2H; Im), 20.46 (br, 9H; Pz-CH3), 19.94 (br,
6H; Im-CH3), 15.25 (br, 2H; Ph), 13.56 (br, 2H; Ph), 13.49 (br, 1H;
Ph), 4.19 (br, 3H; B-CH3), −18.93 (br, 2H; Im), −37.67 (br, 9H; Pz-
CH3). ESI-MS+ (MeCN): m/z = 606 ([M − CH3]+), 397 ([M − LPh
equilibrium constant (KO ).
2
+ MeCN]+). Magnetic moment (Evans method, r.t., CDCl3): μeff
=
3.6 μB. Elemental analysis calcd (%) for [CoII(TpMe2,4H)(LPh)]
(C36H40N10B2Co): C 58.00, H 6.49, N 22.55; found: C 57.60, H 6.29,
N 22.38.
ASSOCIATED CONTENT
■
S
* Supporting Information
The Supporting Information is available free of charge on the
[CoII(TpMe2,4Br)(LPh)] (5). The crude complex was washed with a
small amount of pentane to give the title complex as a beige powder
(130 mg, 0.152 mmol, 22.7%). Recrystallization from a CH2Cl2/
iPrOH solution at room temperature gave a pale brown block crystal
suitable for X-ray crystallography. FT-IR (KBr): ν = 3125 (w), 3045
(w), 2989 (w), 2955 (w), 2902 (vs), 2521 (s, νBH), 1285 cm−1 (s,
νBC). UV−vis (CH2Cl2, r.t.): λ = 684 nm (ε = 21.6 M−1 cm−1), 493
nm (ε = 98.2 M−1 cm−1). 1H NMR (600 MHz, CDCl3, 25 °C, TMS):
δ = 46.68 (br, 1H; B-H), 29.72 (s, 2H; Im), 19.46 (br, 9H; Pz-CH3),
19.02 (s, 6H; Im-CH3), 15.04 (s, 2H; Ph), 13.33 (s, 1H; Ph), 12.74 (s,
2H; Ph), 2.37 (br, 3H; B-CH3), −16.22 (br, 2H; Im), −36.38 (br,
9H; Pz-CH3). ESI-MS+ (MeCN): m/z = 899 ([M + MeCN + H]+).
Magnetic moment (Evans method, r.t., CDCl3): μeff = 3.3 μB.
Elemental analysis calcd (%) for [CoII(TpMe2,4Br)(LPh)]
1H NMR spectra of the cobalt(II) complexes 1−7,
drawings of the sphere-shielding of 1−7 and 1S, space
filling diagrams of 1−7 and 1S, DR-UV−vis spectra of
the solid samples of 6 and 6S, UV−vis spectra in the
reversible O2 sorption/desorption experiments on 1 and
3−7, IR spectra of in situ generated 2S−7S and 2−7 in
CH2Cl2 solutions, crystallographic data and structure
refinement parameters for 1−7 and 1S, and KO values of
2
1−7 under various temperatures (PDF)
I
Inorg. Chem. XXXX, XXX, XXX−XXX